Noetic Fund
Noetic Fund is a Toronto-based investment firm that invests globally in emerging technologies across molecular therapeutics/biotech, digital health, medical devices, and wellness with a primary focus on mental health, pain, and central nervous system (CNS)-targeted therapeutics. The firm seeks to advance scientific development of therapies, modalities, and related products and services aimed at improving mental, emotional, and physiological health.
Services
Equity investment (Seed through Series A and later)
Provides capital and leads financing rounds (examples include leading Seed and Series A investments).
Equity investment (Seed through Series A and later)
Provides capital and leads financing rounds (examples include leading Seed and Series A investments).
Portfolio
Product described as improving resilience to stress, sleep and energy management.
#Wellness / stress resilience / wearable device
Develops psychedelic compounds into licensed pharmaceutical medicines.
#Psychedelic drug development / biotech
Developing ketamine therapies for large-market and orphan indications. CSO & Co-Founder Jeffrey Becker is a Noetic Venture Partner.
#Biotech / ketamine therapies
Noetic Fund II led the company's oversubscribed US$22M Series A (Noetic was majority investor).
#Drug discovery / psychedelic drug engineering
Listed as exited; public listing NASDAQ:CMPS noted on site.
#Clinical-stage mental health care / psychedelic therapeutics
Described as utilizing proprietary drug discovery and delivery platforms.
#Psychedelic therapeutics / drug discovery
Product described as improving resilience to stress, sleep and energy management.
#Wellness / stress resilience / wearable device
Develops psychedelic compounds into licensed pharmaceutical medicines.
#Psychedelic drug development / biotech
Developing ketamine therapies for large-market and orphan indications. CSO & Co-Founder Jeffrey Becker is a Noetic Venture Partner.
#Biotech / ketamine therapies
Noetic Fund II led the company's oversubscribed US$22M Series A (Noetic was majority investor).
#Drug discovery / psychedelic drug engineering
Listed as exited; public listing NASDAQ:CMPS noted on site.
#Clinical-stage mental health care / psychedelic therapeutics
Described as utilizing proprietary drug discovery and delivery platforms.
#Psychedelic therapeutics / drug discovery